150 related articles for article (PubMed ID: 27837636)
1. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.
Tuncel M; Lay Ergun E; Caglar Tuncali M
J BUON; 2016; 21(5):1296-1306. PubMed ID: 27837636
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
3. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
4. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
[TBL] [Abstract][Full Text] [Related]
5. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
6. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
[TBL] [Abstract][Full Text] [Related]
8. Protocol-driven multidetector SPECT/CT: integration of hybrid imaging into the routine workflow of whole-body bone scintigraphy in oncology patients.
Adusumilli P; Nejadhamzeeigilani H; Pitts K; McDermott G; Scarsbrook AF; Vaidyanathan S; Patel CN; Chowdhury FU
Clin Radiol; 2020 Jan; 75(1):79.e1-79.e7. PubMed ID: 31601386
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases.
Zhang Y; Li B; Wu B; Yu H; Song J; Xiu Y; Shi H
Ann Nucl Med; 2020 Aug; 34(8):549-558. PubMed ID: 32583153
[TBL] [Abstract][Full Text] [Related]
10. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases.
Zacho HD; Aleksyniene R; Ejlersen JA; Fledelius J; Petersen LJ
Nucl Med Commun; 2020 Oct; 41(10):1005-1009. PubMed ID: 32694282
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
14. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management.
Sharma P; Singh H; Kumar R; Bal C; Thulkar S; Seenu V; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):139-47. PubMed ID: 22157698
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
Arvola S; Seppänen M; Malaspina S; Mätzke S; Raiko J; Timonen KL; Ettala O; Jambor I; Anttinen M; Kuisma A; Löyttyniemi E; Boström PJ; Sohlberg A; Noponen T
Nucl Med Commun; 2022 May; 43(5):510-517. PubMed ID: 35081092
[TBL] [Abstract][Full Text] [Related]
16. Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
Weissinger M; Kupferschläger J; La Fougère C; Dittmann H; Fiz F
Nuklearmedizin; 2019 Dec; 58(6):451-459. PubMed ID: 31711243
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
Chen R; Yang Q; Chen W; Yang Y; Cheng C; Sun Y; Lu J
World J Urol; 2021 Aug; 39(8):2937-2943. PubMed ID: 33521882
[TBL] [Abstract][Full Text] [Related]
18. Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
Abikhzer G; Gourevich K; Kagna O; Israel O; Frenkel A; Keidar Z
Nucl Med Commun; 2016 Mar; 37(3):247-53. PubMed ID: 26528786
[TBL] [Abstract][Full Text] [Related]
19. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
20. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
Zhang Y; Shi H; Li B; Cai L; Gu Y; Xiu Y
Nuklearmedizin; 2015; 54(6):255-61. PubMed ID: 26615876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
